Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 26, 2023

Beximco Pharms Usa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for BEXIMCO PHARMS USA, and what generic and branded alternatives to BEXIMCO PHARMS USA drugs are available?

BEXIMCO PHARMS USA has seventeen approved drugs.

Summary for Beximco Pharms Usa

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	17

Drugs and US Patents for Beximco Pharms Usa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Beximco Pharms Usa	FLECAINIDE ACETATE	flecainide acetate	TABLET;ORAL	210683-003	Sep 16, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Beximco Pharms Usa	ENALAPRIL MALEATE	enalapril maleate	TABLET;ORAL	075621-003	Aug 22, 2000		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Beximco Pharms Usa	SOTALOL HYDROCHLORIDE	sotalol hydrochloride	TABLET;ORAL	207428-003	Oct 21, 2016	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Beximco Pharms Usa	RIBAVIRIN	ribavirin	TABLET;ORAL	202546-002	Aug 12, 2014		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Beximco Pharms Usa	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	207427-001	Dec 13, 2016	AB1	RX	No	No		See Plans and Pricing				See Plans and Pricing
Beximco Pharms Usa	SOTALOL HYDROCHLORIDE	sotalol hydrochloride	TABLET;ORAL	207428-001	Oct 21, 2016	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Beximco Pharms Usa	RIBAVIRIN	ribavirin	TABLET;ORAL	202546-003	Aug 12, 2014		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Colorcon

Merck

Baxter

Mallinckrodt

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.